Page last updated: 2024-08-24

gemcitabine and myrmicacin

gemcitabine has been researched along with myrmicacin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Babu, R; Byrne, AT; Devocelle, M; Gallagher, WM; Kenny, ST; Nikodinovic-Runic, J; O'Connor, A; O'Connor, KE; O'Connor, S; O'Donovan, N; Szwej, E; Zinn, M; Zulian, QR	1

Other Studies

1 other study(ies) available for gemcitabine and myrmicacin

Article	Year
The anti-cancer activity of a cationic anti-microbial peptide derived from monomers of polyhydroxyalkanoate. Biomaterials, 2013, Volume: 34, Issue:11 Topics: Anticarcinogenic Agents; Antimicrobial Cationic Peptides; Apoptosis; Biocompatible Materials; Biodegradation, Environmental; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Decanoic Acids; Deoxycytidine; Docetaxel; Drug Synergism; Fluorescent Antibody Technique; Gemcitabine; HeLa Cells; HT29 Cells; Humans; Inhibitory Concentration 50; Microscopy, Confocal; Polyhydroxyalkanoates; Taxoids	2013

Article

Year

The anti-cancer activity of a cationic anti-microbial peptide derived from monomers of polyhydroxyalkanoate.

Biomaterials, 2013, Volume: 34, Issue:11

Topics: Anticarcinogenic Agents; Antimicrobial Cationic Peptides; Apoptosis; Biocompatible Materials; Biodegradation, Environmental; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Decanoic Acids; Deoxycytidine; Docetaxel; Drug Synergism; Fluorescent Antibody Technique; Gemcitabine; HeLa Cells; HT29 Cells; Humans; Inhibitory Concentration 50; Microscopy, Confocal; Polyhydroxyalkanoates; Taxoids

2013